Search hospitals > Oregon > Portland
Summit Research Network
Claim this profilePortland, Oregon 97210
Global Leader in Alzheimer's Disease
Global Leader in Depression
Conducts research for Major Depressive Disorder
Conducts research for Migraine
Conducts research for Attention Deficit Hyperactivity Disorder (ADHD)
136 reported clinical trials
3 medical researchers
Summary
Summit Research Network is a medical facility located in Portland, Oregon. This center is recognized for care of Alzheimer's Disease, Depression, Major Depressive Disorder, Migraine, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Summit Research Network is involved with conducting 136 clinical trials across 57 conditions. There are 3 research doctors associated with this hospital, such as Scott Losk, James H. Bergthold, and MaryAnn Conrad.Area of expertise
1Alzheimer's Disease
Global LeaderAβ1-42 positive
APOE4 positive
APOE4 negative
2Depression
Global LeaderTop PIs
Scott LoskSummit Research Network3 years of reported clinical research
Studies Alzheimer's Disease
Studies Dementia
8 reported clinical trials
8 drugs studied
James H. BergtholdSummit Headlands3 years of reported clinical research
Studies Obesity
Studies Diabetes
3 reported clinical trials
3 drugs studied
MaryAnn ConradSummit Headlands1 year of reported clinical research
Studies Diabetes
Studies Obesity
1 reported clinical trial
2 drugs studied
Clinical Trials running at Summit Research Network
Alzheimer's Disease
Dermatomyositis
Vascular Disease
Thrombotic Microangiopathy
AL002
for Alzheimer's Disease
This trial tests AL002, a drug for early Alzheimer's disease, in people who were part of an earlier study. It aims to check if AL002 is safe and effective over time.
Recruiting1 award Phase 2
Oral ABBV-552
for Alzheimer's Disease
This trial tests a new drug called ABBV-552 to see if it can help people aged 50-90 with early Alzheimer's disease. Participants will take the drug daily for a few months, and researchers will check its effects on memory and other symptoms.
Recruiting0 awards Phase 2
ACU193
for Early Alzheimer's Disease
The primary purpose of this study is to evaluate the efficacy of ACU193 infusions administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's disease.
Recruiting0 awards Phase 2 & 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Summit Research Network?
Summit Research Network is a medical facility located in Portland, Oregon. This center is recognized for care of Alzheimer's Disease, Depression, Major Depressive Disorder, Migraine, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Summit Research Network is involved with conducting 136 clinical trials across 57 conditions. There are 3 research doctors associated with this hospital, such as Scott Losk, James H. Bergthold, and MaryAnn Conrad.